1. Alagaratnam TT: Idiopathic gynecomastia treated with tamoxifen; a preliminary report. Clin Ther 9:483-7, 1987.
2. Agarwal VR, Takayama K, Van Wyk JJ, Sasano H, Simpson ER, Bulun SE: Molecular Basis of Severe Gynecomastia Associated with Aromatase Expression in a Fibrolamellar Hepatocellular Carcinoma. Journal of Clinical Endocrinology and Metab 83(5): 1797-1800, 1988.
3. Bahnsen M, Gluud C, Johnsen SG: Pituitary-testicular Function in Patients with Alcoholic Cirrhosis of the Liver. European Journal of Clinical Investigation 11: 473-479, 1981.
4. Bhat N, Rosato E, Gupta P: gynecomastia in a mortician: A case report. Acta Cytol 34:31, 1990.
5. Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Gallucci M, Aragona F, Di Tonno P, Cortellini P, Martorana G, Lapini A, Boccardo F. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Eur Urol . 2010 Feb;57(2):238-45.
6. Berkovitz GD, Guerami, Brown TR, MacDonald PC Migeon CJ: Familial Gynecomastia with Increased Extraglandular Aromatization of Plasma Carbon 19-Steroids. Journal of Clinical Investigation 75: 1763-1769, 1985.
7. Boccardo F, Rubagotti A, Battaglia M, et al: Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 1;23(4):808-15, 2005
8. Bocchinfuso WP, Korach KS: Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice. Journal of Mammary Gland Biology and Neoplasia 90: 323-334, 1997.
9. Braunstein GD. Aromatase and Gynecomastia. Endocrine-Related Cancer 6: 315-324, 1999.
11. Brody SA, Loriaux DL. Epidemic of gynecomastia among haitian refugees: exposure to an environmental antiandrogen. Endocr Pract 9(5):370-5, Set-Oct, 2003.
12. Calzada L, Torres-Calleja JM, Martinez N: Measurement of Androgen and Estrogen Receptors in Breast Tissue from Subjects with Anabolic Steroid-Dependent Gynecomastia. Life Sciences 69 (2110): 1465-1479.
13. Carlson HE, Kane P, Lei ZM, et al: Presence of luteinizing hormone/human chorionic gonadotropin receptors in male breast tissues. J Clin Endocrinol Metab 89(8):4119-23, 2004.
14. Chan WB, Yeung VT, Chow CC, So WY, Cockram CS: Gynaecomastia as a Presenting Feature of Thyrotoxicosis. Postgraduate Medical Journal 75(882): 229-231, 1999.
15. Chou JL, Easley JD, Feldmeier JJ, Rauth VA, Pomeroy TC. Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy. Int J Radiat Oncol Biol Phys 15(3):749-51, 1988.
16. Coen P, Kulin H, Ballantine T, Zaino r, Frauenhoffer E, Boal D, Inkster S, Brodie A, Santen R: An Aromatase-Producing Sex-cord Tumor Resulting in Prepubertal Gynecomastia. New England Journal of Medicine 324 (5): 317-22, 1991.
17. Czajka-Oraniec I , Zgliczynski W , Kurylowicz A , Mikula M , Ostrowski J . Association between gynecomastia and aromatase (CYP19) polymorphisms. Eur J Endocrinol. 2008 May;158(5):721-7.
18. Dimitriadis G, Papadopoulos V, Mimidis K. Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics. Hepatol Int . 2011 Jun;5(2):738-9
19. Edman DC, Hemsell DL, Brenner PF: Extraglandular Estrogen Formation in Subjects with Cirrhosis. Gastroenterology 69: 819, 1975.
20. Fentiman IS , Fourquet A , Hortobagyi GN : Male breast cancer. Lancet 367(9510):595-604, 2006.
21. Finkelstein J, McCully W, MacLaughlin D, et al.: The mortician's mystery: Gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Eng J Med 319:961, 1988.
22 . Fradet Y, Egerdie B, Andersen M, Tammela TL, Nachabe M, Armstrong J, Morris T, Navani S. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol . 2007 Jul;52(1):106-14
23. Franz A, Wilson J: Williams Textbook of Endocrinology ninth edition, 877-885, 1998.
24. Gana BM: Leydig Cell Tumor, British Journal of Urology 75(5): 676-8, 1995.
25. Gill K, Kirma N, Tekmal RR: Overexpression of Aromatase in Transgenic Male Mice Results in the Induction of Gynecomastia and other Biochemical Changes in Mammary Gland. Journal of Steroid Biochemistry and Molecular Biology 77(1):13-18, 2001.
26. Glass AR: Gynecomastia. Endocrinology and Metabolism Clinics of North America. 23(4): 825-837, 1994.
27. Hammond DC. Surgical correction of gynecomastia. Plast Reconstr Surg . 2009 Jul;124(1 Suppl):61e-68e.
28. Herito RJ, Dankner R, Berezin M, Zeilig G, Ohry A: Gynecomastia Following Spinal Cord Disorder. Archives of Physical Medicine and Rehabilitation 78(5): 534-537, 1997.
29. Hertl MC, Wiebel J, Schafer H, Willig HP, Lambrecht W. Feminizing Sertoli Cell Tumors Associated with Peutz-Jeghers Syndrome: An Increasingly Recognized Cause of Prepubertal Gynecomastia. Plastic Reconstructive Surgery 102(4):1151-57, 1998.
30. Hormone Foundation. Patient information page. Gynecomastia. J Clin Endocrinol Metab . 2011 Jan;96(1):0
31. Hsing A, McLaughlin J, Cocco p, Chen H, Fraumeni JF: Risk factors for male breast cancer. Cancer Causes and Control 9; 269-275, 1998.
32. Ikard RW, Vavra D, Forbes RC, Richman JC, Roumie CL. Management of senescent gynecomastia in the Veterans Health Administration. Breast J . 2011 Mar;17(2):160-6. doi: 10.1111/j.1524-4741.2010.01050.x.
33. Jarrar G, Peel A, Fahmy R, Deol H, Salih V, Mostafa A. Single incision endoscopic surgery for gynaecomastia. J Plast Reconstr Aesthet Surg . 2011 May 12.
34. Johnson RE, Murad MH. Gynecomastia: Pathophysiology, Evaluation, and Management Mayo Clin Proc. 2009;84(11):1010-1015.
35. Jones DJ, Holt SD, Surtees P, et al: A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. Ann R Coll Surg Engl, 72:296-8, 1990.
36. Kleinberg DL, Feldman M, Ruan W: IGF-1: An Essential Factor in Terminal End Bud Formation and Ductal Morphogenesis. Journal of Mammary Gland Biology and Neoplasia 5(1):7-17, 2000.
37. Koh J , Tee A . Images in clinical medicine. Tuberculous abscess manifesting as unilateral gynecomastia. N Engl J Med. 2009 Dec 3;361(23):2270.
38. Kuhn JM, Roca R, Laudat MH, et al: Studies on the treatment of idiopathic gynecomastia with percutaneous dihydrotestosterone. Clin Endo 19: 513-20, 1983.
39. Lawrence SE , Faught KA , Vethamuthu J , Lawson ML Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr ;145(1):71-6 ,2004.
40. LeProvost F, Leroux, C, Martin P Gaye P, Djiane, J, Prolactin Gene Expression in Ovine and Caprine Mammary Gland, Neuroendocrinology 60: 305-313, 1994.
41. Leroith D, Sobel R, Glick SM: The effect of clomiphene citrate on pubertal gynaecomastia. Acta Endocrinol (copenh). 95:177-80, 1980.
42. Li X, Warri A, Makela S, Ahonen T, Streng T, Santti R, Poutanen M. Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 143(10):4074-83, 2002.
43. Lubahn, DB, Moyer JS, Golding TS: Alteration of Reproductive Function but not Prenatal Sexual Development after Insertional Disruption of the Mouse Estrogen Receptor Gene. Proc Soc Natl Acad Sci USA 90:11162-11166, 1993.
44. Mahoney CP: Adolescent Gynecomastia. Differential Diagnosis and Management. Pediatric Clinics of North America 37(6): 1389-1404, 1990.
45. Mathur R, Braunstein: Gynecomastia: Pathomechanisms and Treatment Strategies. Hormone Research 48:95-102, 1997.
46. Matoska J, Ondrus D, Talerman A: Malignant Granulosa Cell Tumor of the Testes Associated with Gynecomastia and LongSurvival. Cancer 69(7): 1769-72, 1992.
47. Miller WR, Jackson J: The therapeutic potential of aromatase inhibitors. Expert Opin Investig Drugs 12(3):337-51, Mar, 2003.
48. Mol JA, Van Garderen E, Rutteman GR, Rijnberk A: New Insights in the Molecular Mechanism of Progestin-induced Proliferation of Mammary Epithelium: Induction of the Local Biosynthesis of Growth Hormone in the Mammary Gland of Dogs, Cats, and Humans. Journal of Steroid Biochemistry and Molecular Biology 57 (1-2): 67-71, 1996.
49. Moore DC, Schlaepfer, LP, Sizonenko PC: Hormonal Changes During Puberty: Transient Pubertal Gynecomastia; Abnormal Androgen-Estrogen Ratios. Journal of Clinical Endocrinology and Metabolism 58:492-499, 1984.
50. Moran CA, Suster S: Primary Mediastinal Choriocarcinoma: A Clinicopathologic and Immunohistochemical Study of Eight Cases. American Journal of Surgical Pathology 21(9): 1007-1012, 1997.
51. Muramori K, Taguchi S, Taguchi T, Kohashi K, Furuya K, Tokuda K, Ishii E . High Aromatase Activity and Overexpression of Epidermal Growth Factor Receptor in Fibrolamellar Hepatocellular Carcinoma in a Child. J Pediatr Hematol Oncol . 2011. May 5.
52. Niewoehner CB, Nuttall FQ: Gynecomastia in Hospitalized Male Population. American Journal of Medicine 77: 633-638, 1984.
54. Olivo J, Gordon GG, Raifi F: Estrogen Metabolism in Hyperthyroidism and in Cirrhosis of the Liver. Steroids 26: 47-56, 1975.
55. Ozen H, Akyol F, Toktas G, Eskicorapci S, Unluer E, Kuyumcuoglu U, Abay E, Cureklibatur I, Sengoz M, Yalcin V, Akpinar H, Zorlu F, Sengor F, Karaman I. Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain? J Urol . 2010 Aug;184(2):519-24.
56. Parthasarathy HK, Ménard J, White WB, Young WF Jr, Williams GH, Williams B, Ruilope LM, McInnes GT, Connell JM, Macdonald TM. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens . 2011 May;29(5):980-990.
57. Perdonà S, Autorino R, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Bianco AR, Di Lorenzo G. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol . 2005 May;6(5):295-300.
58. Plourde PV, Reiter EO, Jou HC, Desrochers PE, Rubin SD, Bercu BB, Diamond FB Jr, Backeljauw PF : Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89(9):4428-33, 2004.
59. Richie J: Campbell's Urology 7th Edition, 2439-2443, 1998.
60. Riepe FG, Baus I, Wiest S, et al: Treatment of Pubertal Gynecomastia with the Specific Aromatase Inhibitor Anastrozole. Horm Res 20;62(3):113-118, 2004.
61 . Rifka SM, Pita JC, Vigersky RA, et al. Interaction of digitalis and spironolactone with human sex steroid receptors. J Clin Endocrinol Metab 1977; 46:228-244.
62. Ruan W, Kleinberg DL: Insulin-like Growth Factor I is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development. Endocrinology 140(11): 5075-81, 1999.
63. Saltzstein D, Sieber P, Morris T, Gallo J: Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 8(1):75-83. 2005.
64. Santen R: Endocrinology fourth edition vol. 3: 2335-2341, 2001.
65. Sasano H, Kimura m, Shizawa s, Kimura N, Nagua H, Aromatase and Steroid Receptors in Gynecomastia and Male Breast Carcinoma: an Immunohistochemical Study. Journal of Clinical Endocrinology and Metabolism 81 (8): 3063-7, 1996.
66. Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M, Bulun SE. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 8;348(19):1855-65, May, 2003.
67. Singh Narula H, Carlson HE. Gynaecomastia. Endocrinol Metab Clin North Am2007;48:497-519.
68. Steinmetz R, Grant A, Malven, P: Transcription of Prolactin Gene in Milk Secretory Cells of the Rat Mammary Gland. Journal of Endocrinology 36: 305-313,1993.
69. Thompson DF, Carter J: Drug-induced gynecomastia. Pharmacotherapy 13(1): 37-45, 1993.
70. Ting AC, Chow LW, Leung YF: Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia. Am Surg 66(1):38-40, 2000.
71. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients. J Sex Med . 2010 Dec 22. doi: 10.1111/j.1743-6109.2010.02157.x
72. Treves N: Gynecomastia: the origins of mammary swelling in the male: and analysis of 406 patients with breast hypertrophy, 525 with testicular tumors, and 13 with adrenal neoplasms. Cancer 11: 1083-102, 1958.
73. Voelker R. Estrogen spray poses risks to children, pets through contact with treated skin. JAMA . 2010 Sep 1;304(9):953.
74.Widmark A, Fossa SD, Lundmo P, Damber JE, Vaage S,Damber L, Wiklund F, Klepp O.: Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. J Urol 170(1):320, 2003.
75. Walden PD, Ruan W, Feldman M, Kleinberg DL: Evidence that the Mammary Fat Pad Mediated the Action of Growth Hormone in Mammary Gland Development, Endocrinology 139 (2): 659-62, 1998.
76. Young S, Gooneratne S. Straus FH 2nd, Zeller WP, Bulun SE, Rosenthal IM: Feminizing Sertoli Cell Tumors in Boys with Peutz-Jehgers Syndrome. American Journal of Surgical Pathology 19 (1):50-58, 1995.
77. Zachmann M, Eiholzer U, Muritano M, et al: Treatment of pubertal gynaecomastia with testolactone. Acta Endocrinol supple (copenh) 279:218-26, 1986.